
Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-Acting Antivirals
Keywords: Cryoglobulinemic Vasculitis; Hepatitis C; DAA; Antiviral Therapy; ACC; asymptomatic circulating cryoglobulins; BVAS.v3; Birmingham Vasculitis Activity Score version 3; C4; complement 4 fraction; CH50; 50% hemolytic complement activity; CV; cryoglobulinemi